secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2023-04-05T23:59:59+00:00
Accession:  0000950170-23-011909
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Lyn Baranowski will not stand for re-election at 2023 annual meeting
-----------------------------------------------------------------------------

- Lyn Baranowski notified Rani Therapeutics she will not stand for re-election at the 2023 annual meeting.
- She will cease to be a board member and member of Compensation and Nominating/Governance committees effective at the meeting.
- Decision not due to any disagreement with the company on operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000095017023011909/0000950170-23-011909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000095017023011909/rani-20230330.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-011909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer